MedTrace Logo

A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort

NCT03731637 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2269

Last updated 2025-04-30

No results posted yet for this study

Summary

Create a large biobank of blood samples and data from subjects with new onset hyperglycemia and diabetes (NOD).

Conditions

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    collaborator OTHER

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Suresh Chari, MD · M.D. Anderson Cancer Center

  • Anirban Maitra, MBBS · M.D. Anderson Cancer Center

  • Bechien Wu, MD · Kaiser Permanente Southern Califorina

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-15
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03731637 on ClinicalTrials.gov